Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma
Clinical trial NCT02258529 · TERMINATED
Trial details
- NCT number
- NCT02258529
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-14
- Primary completion
- 2016-04-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.